Health And Medicine
-
Drivers of breast cancer metastasis
Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported. Read MoreJul 20, 2017
-
Economist explains impacts of Senate health plan
Vanderbilt University economist Andrew Goodman-Bacon, who studies the long-term effects of public safety net programs like Medicaid, gives his take on the latest Senate health care proposal. Read MoreJul 17, 2017
-
Study seeks to improve emergency event management
Anesthesiology has a long history of scrutinizing its practice and developing strategies for improvement. Read MoreJul 13, 2017
-
New approach for staph-related skin abscesses explored
New multicenter research that includes Vanderbilt University Medical Center (VUMC) investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria. Read MoreJul 13, 2017
-
Bile acids, microbiota and colon cancer
Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis. Read MoreJul 5, 2017
-
NOTCH1 role in heart development
The identification of a genetic culprit for hypoplastic left heart syndrome could lead to new treatments for the condition. Read MoreJul 3, 2017
-
Cytokine linked to blindness
A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered. Read MoreJun 30, 2017
-
Team investigates antiviral that inhibits SARS, MERS
A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. Read MoreJun 29, 2017
-
Genetics of lung cancer survival
Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans. Read MoreJun 29, 2017
-
VU scientists report a way to calm the sepsis “storm”
Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis. Read MoreJun 22, 2017
-
STINGing combination for cancer
A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. Read MoreJun 19, 2017
-
Heart disease incidence down for men in Tennessee
There's good and bad news in the new Tennessee Men's Health Report Card. Read MoreJun 14, 2017
-
PET imaging to predict tumor response
A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models. Read MoreJun 14, 2017
-
Drug developed for arthritis could be first to stop heart valve calcification
The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Read MoreJun 12, 2017
-
Repriming replication roadblocks
New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away. Read MoreJun 12, 2017
-
Flip side of gut protection
Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease. Read MoreJun 9, 2017
-
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). Read MoreJun 8, 2017
-
Vanderbilt-led study disputes link between uterine fibroids and miscarriage risk
A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, M.D., Ph.D., disrupts conventional wisdom that uterine fibroids cause miscarriages. Read MoreJun 7, 2017
-
Forum highlights innovative approaches to bolstering biomedical research
How can we — together — make research at Vanderbilt University Medical Center (VUMC) better and stronger? Read MoreJun 1, 2017
-
Preserving NIH’s Fogarty International Center crucial for global health efforts
This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH). Read MoreMay 26, 2017